• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
UNS
Click for more information
0.00% 0.5¢

UNILIFE CORPORATION - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
UNS Register Balances (29.02.16)29/03/16
UNS Appendix 3B18/03/16
UNS Final Director's Interest Notice16/03/16
UNS Unilife Leadership Transition15/03/16
UNS 8K - Unilife Leadership Transition15/03/16
UNS S&P DJ Indices Announces March Quarterly Review11/03/16
UNS Amgen 13G Form07/03/16
UNS Register Balances (31.01.16)01/03/16
UNS Strategic Collaboration with Amgen Inc.PRICE SENSITIVE23/02/16
UNS OrbiMed Prospectus Supplement (23.02.16)23/02/16
UNS Appendix 3B and Cleansing Notice (23.02.16)23/02/16
UNS Amgen & OrbiMed 8-K23/02/16
UNS Appendix 3B18/02/16
UNS 8-K Amgen Extension17/02/16
UNS Ceasing to be a substantial holder17/02/16
UNS Half Year AccountsPRICE SENSITIVE10/02/16
UNS Unilife 10Q 2016 Q210/02/16
UNS Earnings Release Q2 2016PRICE SENSITIVE10/02/16
UNS Unilife - Date for Release of Results Q2 201609/02/16
UNS 8-K Amgen Extension - Amendment of Date of Cover Letter08/02/16
UNS 8-K Amgen Extension08/02/16
UNS Appendix 3B04/02/16
UNS 8-K Discover Fund Agreement04/02/16
UNS 8-K Amgen and Orbimed Amendment Agreements02/02/16
UNS Appendix 4C - quarterlyPRICE SENSITIVE29/01/16
UNS Register Balances (31.12.15)22/01/16
UNS Appendix 3B15/01/16
UNS Appendix 3B08/01/16
UNS 8-K Orbimed Agreement Amendment (08.01.16)08/01/16
UNS Unilife 8-K Exclusivity Agreement04/01/16
UNS Register Balances (30.12.15)23/12/15
UNS Appendix 3B23/12/15
UNS Notice of Annual General Meeting/Proxy Form17/12/15
UNS Change of Director's Interest Notice15/12/15
UNS Appendix 3B14/12/15
UNS Unilife 8-K (07.12.15)07/12/15
UNS Register Balances (31.10.15)02/12/15
UNS Appendix 3B25/11/15
UNS Unilife 8-K25/11/15
UNS Change of Director's Interest Notice x 520/11/15
UNS Appendix 3B20/11/15
UNS Results of Meeting18/11/15
UNS Appendix 3B10/11/15
UNS Appendix 3B & Cleansing Notice10/11/15
UNS Unilife 8-K (10.11.15)10/11/15
UNS Unilife - Prospectus Supplement (10.11.15)10/11/15
UNS Q1 2016 ResultsPRICE SENSITIVE10/11/15
UNS Earnings Call Q1 201610/11/15
UNS Response to ASX Aware QueryPRICE SENSITIVE09/11/15
UNS Change of Director's Interest Notice05/11/15
UNS MedImmune Supply AgreementPRICE SENSITIVE05/11/15
UNS Appendix 4C - quarterlyPRICE SENSITIVE30/10/15
UNS Unilife - Q1 2016 Conference Call27/10/15
UNS Unilife - US$10M Financing and Cost ReductionsPRICE SENSITIVE19/10/15
UNS Unilife 8-K19/10/15
UNS Register Balances (30.09.15)13/10/15
UNS Appendix 3B13/10/15
UNS Unilife Lodges 8K (07.10.15)08/10/15
UNS Notice of Annual General Meeting/Proxy Form05/10/15
UNS Register Balances (31.08.15)25/09/15
UNS Appendix 3B25/09/15
UNS Unilife - Novartis Novel Delivery ProgramPRICE SENSITIVE25/09/15
UNS Earnings Call Q4 2015 (15.09.15)15/09/15
UNS Appendix 4G (15.09.15)15/09/15
UNS Full Year Statutory Accounts - 10K15/09/15
UNS Unilife - Q4 2015 Conference Call09/09/15
UNS Appendix 3B04/09/15
UNS Unilife Announces Review of Strategic AlternativesPRICE SENSITIVE03/09/15
UNS Register Balances (31.07.15)01/09/15
UNS Preliminary Final ReportPRICE SENSITIVE31/08/15
UNS ASX Waiver Notice27/08/15
UNS Initial Director's Interest Notice26/08/15
UNS Final Director's Interest Notice26/08/15
UNS Appendix 3B & Cleansing Notice26/08/15
UNS Unilife Director Appointment 8-K (26.08.15)26/08/15
UNS Director Appointment/Resignation26/08/15
UNS Former Employee Withdraws Lawsuit20/08/15
UNS Unilife Lodges 8-K (20.08.15)20/08/15
UNS Appendix 4C - quarterlyPRICE SENSITIVE31/07/15
UNS Unilife Imperium Investor Presentation (31.07.15)31/07/15
UNS LPC 8-K & Prospectus Supplement31/07/15
UNS ATM 8-K & Prospectus SupplementPRICE SENSITIVE31/07/15
UNS Appendix 3B & Cleansing Statement30/07/15
UNS Unilife FinancingPRICE SENSITIVE30/07/15
UNS Imperium - World's First Instant Patch PumpPRICE SENSITIVE30/07/15
UNS Register Balances (30.06.15)17/07/15
UNS Appendix 3B17/07/15
UNS Unilife - Orbimed Amendment02/07/15
UNS Unilife 8K - Orbimed Amendment02/07/15
UNS Results of Meeting24/06/15
UNS CEO Alan Shortall Wins EY Entrepreneur Award16/06/15
UNS Register Balances (31.05.15)15/06/15
UNS Change of registry address12/06/15
UNS Change of Share Registry Address12/06/15
UNS Unilife to Present at Jefferies Healthcare Conference29/05/15
UNS Appendix 3B25/05/15
UNS Register Balances (30.04.15)25/05/15
UNS Change of Director's Interest Notice14/05/15
UNS Unilife Q3 2015 Presentation12/05/15
UNS Unilife Q3 2015 ResultsPRICE SENSITIVE12/05/15
UNS Register Balances (29.02.16)
29/03/16
UNS Appendix 3B
18/03/16
UNS Final Director's Interest Notice
16/03/16
UNS Unilife Leadership Transition
15/03/16
UNS 8K - Unilife Leadership Transition
15/03/16
UNS S&P DJ Indices Announces March Quarterly Review
11/03/16
UNS Amgen 13G Form
07/03/16
UNS Register Balances (31.01.16)
01/03/16
UNS Strategic Collaboration with Amgen Inc.
23/02/16PRICE SENSITIVE
UNS OrbiMed Prospectus Supplement (23.02.16)
23/02/16
UNS Appendix 3B and Cleansing Notice (23.02.16)
23/02/16
UNS Amgen & OrbiMed 8-K
23/02/16
UNS Appendix 3B
18/02/16
UNS 8-K Amgen Extension
17/02/16
UNS Ceasing to be a substantial holder
17/02/16
UNS Half Year Accounts
10/02/16PRICE SENSITIVE
UNS Unilife 10Q 2016 Q2
10/02/16
UNS Earnings Release Q2 2016
10/02/16PRICE SENSITIVE
UNS Unilife - Date for Release of Results Q2 2016
09/02/16
UNS 8-K Amgen Extension - Amendment of Date of Cover Letter
08/02/16
UNS 8-K Amgen Extension
08/02/16
UNS Appendix 3B
04/02/16
UNS 8-K Discover Fund Agreement
04/02/16
UNS 8-K Amgen and Orbimed Amendment Agreements
02/02/16
UNS Appendix 4C - quarterly
29/01/16PRICE SENSITIVE
UNS Register Balances (31.12.15)
22/01/16
UNS Appendix 3B
15/01/16
UNS Appendix 3B
08/01/16
UNS 8-K Orbimed Agreement Amendment (08.01.16)
08/01/16
UNS Unilife 8-K Exclusivity Agreement
04/01/16
UNS Register Balances (30.12.15)
23/12/15
UNS Appendix 3B
23/12/15
UNS Notice of Annual General Meeting/Proxy Form
17/12/15
UNS Change of Director's Interest Notice
15/12/15
UNS Appendix 3B
14/12/15
UNS Unilife 8-K (07.12.15)
07/12/15
UNS Register Balances (31.10.15)
02/12/15
UNS Appendix 3B
25/11/15
UNS Unilife 8-K
25/11/15
UNS Change of Director's Interest Notice x 5
20/11/15
UNS Appendix 3B
20/11/15
UNS Results of Meeting
18/11/15
UNS Appendix 3B
10/11/15
UNS Appendix 3B & Cleansing Notice
10/11/15
UNS Unilife 8-K (10.11.15)
10/11/15
UNS Unilife - Prospectus Supplement (10.11.15)
10/11/15
UNS Q1 2016 Results
10/11/15PRICE SENSITIVE
UNS Earnings Call Q1 2016
10/11/15
UNS Response to ASX Aware Query
09/11/15PRICE SENSITIVE
UNS Change of Director's Interest Notice
05/11/15
UNS MedImmune Supply Agreement
05/11/15PRICE SENSITIVE
UNS Appendix 4C - quarterly
30/10/15PRICE SENSITIVE
UNS Unilife - Q1 2016 Conference Call
27/10/15
UNS Unilife - US$10M Financing and Cost Reductions
19/10/15PRICE SENSITIVE
UNS Unilife 8-K
19/10/15
UNS Register Balances (30.09.15)
13/10/15
UNS Appendix 3B
13/10/15
UNS Unilife Lodges 8K (07.10.15)
08/10/15
UNS Notice of Annual General Meeting/Proxy Form
05/10/15
UNS Register Balances (31.08.15)
25/09/15
UNS Appendix 3B
25/09/15
UNS Unilife - Novartis Novel Delivery Program
25/09/15PRICE SENSITIVE
UNS Earnings Call Q4 2015 (15.09.15)
15/09/15
UNS Appendix 4G (15.09.15)
15/09/15
UNS Full Year Statutory Accounts - 10K
15/09/15
UNS Unilife - Q4 2015 Conference Call
09/09/15
UNS Appendix 3B
04/09/15
UNS Unilife Announces Review of Strategic Alternatives
03/09/15PRICE SENSITIVE
UNS Register Balances (31.07.15)
01/09/15
UNS Preliminary Final Report
31/08/15PRICE SENSITIVE
UNS ASX Waiver Notice
27/08/15
UNS Initial Director's Interest Notice
26/08/15
UNS Final Director's Interest Notice
26/08/15
UNS Appendix 3B & Cleansing Notice
26/08/15
UNS Unilife Director Appointment 8-K (26.08.15)
26/08/15
UNS Director Appointment/Resignation
26/08/15
UNS Former Employee Withdraws Lawsuit
20/08/15
UNS Unilife Lodges 8-K (20.08.15)
20/08/15
UNS Appendix 4C - quarterly
31/07/15PRICE SENSITIVE
UNS Unilife Imperium Investor Presentation (31.07.15)
31/07/15
UNS LPC 8-K & Prospectus Supplement
31/07/15
UNS ATM 8-K & Prospectus Supplement
31/07/15PRICE SENSITIVE
UNS Appendix 3B & Cleansing Statement
30/07/15
UNS Unilife Financing
30/07/15PRICE SENSITIVE
UNS Imperium - World's First Instant Patch Pump
30/07/15PRICE SENSITIVE
UNS Register Balances (30.06.15)
17/07/15
UNS Appendix 3B
17/07/15
UNS Unilife - Orbimed Amendment
02/07/15
UNS Unilife 8K - Orbimed Amendment
02/07/15
UNS Results of Meeting
24/06/15
UNS CEO Alan Shortall Wins EY Entrepreneur Award
16/06/15
UNS Register Balances (31.05.15)
15/06/15
UNS Change of registry address
12/06/15
UNS Change of Share Registry Address
12/06/15
UNS Unilife to Present at Jefferies Healthcare Conference
29/05/15
UNS Appendix 3B
25/05/15
UNS Register Balances (30.04.15)
25/05/15
UNS Change of Director's Interest Notice
14/05/15
UNS Unilife Q3 2015 Presentation
12/05/15
UNS Unilife Q3 2015 Results
12/05/15PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.